Treatment Of Hepatorenal Syndrome Stocks List
Symbol | Grade | Name | % Change | |
---|---|---|---|---|
CPIX | F | Cumberland Pharmaceuticals Inc. | 4.64 | |
BIVI | F | BioVie Inc. | -1.90 |
Related Industries: Biotechnology Drug Manufacturers - Specialty & Generic
Related ETFs - A few ETFs which own one or more of the above listed Treatment Of Hepatorenal Syndrome stocks.
Symbol | Grade | Name | Weight | |
---|---|---|---|---|
VTWG | C | Vanguard Russell 2000 Growth ETF | 0.0 | |
IWC | B | iShares Microcap ETF | 0.0 | |
DFAT | B | Dimensional U.S. Targeted Value ETF | 0.0 | |
UWM | D | ProShares Ultra Russell2000 | 0.0 | |
DFAC | C | Dimensional U.S. Core Equity 2 ETF | 0.0 |
Compare ETFs
Related Industries:
Biotechnology
Drug Manufacturers - Specialty & Generic
- Treatment Of Hepatorenal Syndrome
Treatment of hepatorenal syndrome (HRS) is aimed at improving kidney function and preventing further damage to the kidneys. Treatment options may include medications to reduce the amount of fluid in the body, medications to reduce the amount of toxins in the blood, and dialysis. In some cases, a liver transplant may be necessary.
Popular Now
Recent Comments
- TraderMike on IZM
- SuccessfulGerbil321 on IZM
- TraderMike on IZM
- TraderMike on Today's Outage
- Crunching_The_Market on Today's Outage
From the Blog
Featured Articles